207 related articles for article (PubMed ID: 25724651)
81. Mutational switching of a yeast tRNA synthetase into a mammalian-like synthetase cytokine.
Liu J; Yang XL; Ewalt KL; Schimmel P
Biochemistry; 2002 Dec; 41(48):14232-7. PubMed ID: 12450387
[TBL] [Abstract][Full Text] [Related]
82. The NH2-terminal extension of rat liver arginyl-tRNA synthetase is responsible for its hydrophobic properties.
Huang S; Deutscher MP
Biochem Biophys Res Commun; 1991 Oct; 180(2):702-8. PubMed ID: 1953742
[TBL] [Abstract][Full Text] [Related]
83. Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).
Lal CV; Schwarz MA
Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):180-8. PubMed ID: 24619875
[TBL] [Abstract][Full Text] [Related]
84. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
Kayton ML; Libutti SK
Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
[TBL] [Abstract][Full Text] [Related]
85. Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein.
Quevillon S; Robinson JC; Berthonneau E; Siatecka M; Mirande M
J Mol Biol; 1999 Jan; 285(1):183-95. PubMed ID: 9878398
[TBL] [Abstract][Full Text] [Related]
86. HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.
Green LA; Yi R; Petrusca D; Wang T; Elghouche A; Gupta SK; Petrache I; Clauss M
Am J Physiol Lung Cell Mol Physiol; 2014 Feb; 306(4):L372-82. PubMed ID: 24318111
[TBL] [Abstract][Full Text] [Related]
87. Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.
van Horssen R; Rens JA; Brunstein F; Guns V; van Gils M; Hagen TL; Eggermont AM
Int J Cancer; 2006 Sep; 119(6):1481-90. PubMed ID: 16615114
[TBL] [Abstract][Full Text] [Related]
88. Apoptosis induced by a corneal-endothelium-derived cytokine.
Liu SH; Gottsch JD
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3152-9. PubMed ID: 10586937
[TBL] [Abstract][Full Text] [Related]
89. EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.
Youssef MM; Symonds P; Ellis IO; Murray JC
Br J Cancer; 2006 Sep; 95(6):735-43. PubMed ID: 16929248
[TBL] [Abstract][Full Text] [Related]
90. Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease.
Emingil G; Atilla G; Başkesen A; Berdeli A
J Clin Periodontol; 2005 Aug; 32(8):880-5. PubMed ID: 15998272
[TBL] [Abstract][Full Text] [Related]
91. Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity.
Liang D; Halpert MM; Konduri V; Decker WK
Int Rev Immunol; 2015; 34(5):367-81. PubMed ID: 26325028
[TBL] [Abstract][Full Text] [Related]
92. Acetylation of lysine ϵ-amino groups regulates aminoacyl-tRNA synthetase activity in
Ye Q; Ji QQ; Yan W; Yang F; Wang ED
J Biol Chem; 2017 Jun; 292(25):10709-10722. PubMed ID: 28455447
[TBL] [Abstract][Full Text] [Related]
93. Degradation of the arginyl-tRNA synthetase protein during purification by affinity chromatography on immobilized total tRNA and immobilized tRNA, specific for arginyl-tRNA synthetase.
Berg BH
Biochem Mol Biol Int; 1993 Oct; 31(2):219-28. PubMed ID: 8275012
[TBL] [Abstract][Full Text] [Related]
94. A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro.
Rajashekhar G; Mitnacht-Kraus R; Ispe U; Garrison J; Hou Y; Taylor B; Petrache I; Vestweber D; Clauss M
J Immunol Methods; 2009 Oct; 350(1-2):22-8. PubMed ID: 19683532
[TBL] [Abstract][Full Text] [Related]
95. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
Kao J; Houck K; Fan Y; Haehnel I; Libutti SK; Kayton ML; Grikscheit T; Chabot J; Nowygrod R; Greenberg S
J Biol Chem; 1994 Oct; 269(40):25106-19. PubMed ID: 7929199
[TBL] [Abstract][Full Text] [Related]
96. Symmetric Assembly of a Decameric Subcomplex in Human Multi-tRNA Synthetase Complex Via Interactions between Glutathione Transferase-Homology Domains and Aspartyl-tRNA Synthetase.
Cho HY; Lee HJ; Choi YS; Kim DK; Jin KS; Kim S; Kang BS
J Mol Biol; 2019 Nov; 431(22):4475-4496. PubMed ID: 31473157
[TBL] [Abstract][Full Text] [Related]
97. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
Tandle AT; Mazzanti C; Alexander HR; Roberts DD; Libutti SK
Cytokine; 2005 Jun; 30(6):347-58. PubMed ID: 15935955
[TBL] [Abstract][Full Text] [Related]
98. Monoclonal antibodies against tyrosyl-tRNA synthetase and its isolated cytokine-like domain.
Kondratiuk I; Khoruzenko A; Cherednyk O; Filonenko V; Kornelyuk A
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):200-4. PubMed ID: 23750478
[TBL] [Abstract][Full Text] [Related]
99. A distinct transcriptional profile in response to endothelial monocyte activating polypeptide II is partially mediated by JAK-STAT3 in murine macrophages.
Lee DD; Hochstetler A; Murphy C; Lowe CW; Schwarz MA
Am J Physiol Cell Physiol; 2019 Sep; 317(3):C449-C456. PubMed ID: 31216192
[TBL] [Abstract][Full Text] [Related]
100. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.
Kao J; Ryan J; Brett G; Chen J; Shen H; Fan YG; Godman G; Familletti PC; Wang F; Pan YC
J Biol Chem; 1992 Oct; 267(28):20239-47. PubMed ID: 1400342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
